期刊文献+

脑脊液检测对隐球菌性脑膜炎的临床意义 被引量:1

The clinical significance of the cerebrospinal fluid examination in cryptococcal meningitis
下载PDF
导出
摘要 目的探讨脑脊液(CSF)检测对隐球菌性脑膜炎(CM)的临床诊断、治疗及预后的意义。方法分析36例CM患者的CSF动态变化、疗效及转归。结果 CM患者在治疗前32例(88.9%)CSF压力升高、34例(94.4%)墨汁染色阳性、26例(72.2%)白细胞总数升高、33例(91.7%)蛋白质含量升高、27例(75.0%)氯化物含量降低,治疗后6例(33.3%)脑脊液压力升高、4例(22.2%)墨汁染色阳性、8例(44.4%)白细胞总数升高、10例(55.6%)蛋白质含量升高、4例(22.2%)氯化物含量降低,且上述指标均呈动态变化。36例患者中治愈17例(47.2%),好转10例(27.8%),死亡9例(死于脑疝)(25%)。结论脑脊液检查是CM临床诊断最重要的手段,在治疗过程中可作为动态观察CM疗效的指标。 Objective To investigate the significance of cerebrospinal fluid(CSF)examination for clinical diagnosis,treatment and prognosis in cryptococcal meningitis.Methods Analyze the dynamic changes of cerebrospinal fluid(CSF)of 36 patients with cryptococcal meningitis and observe the therapeutic effect and turnover.Results Before the treatment,CSF pressure increased in 32 patients(88.9%),India ink capsule staining was positive in 34 patients(94.4%),total leucocytes increased in 26 patients(72.2%),protein content increased in 33 patients(91.7%),chloride content decreased in 27 patients(75.0%).After the treatment,CSF pressure increased in 6 patients(33.3%),India ink capsule staining was positive in 4 patients(22.2%),total leucocytes increased in 8 patients(44.4%),protein content increased in 10 patients(55.6%),chloride content decreased in 4 patients(22.2%).These indexes changes in CSF were dynamic during the treatment.In the 36 patients,17 patients were cured(47.2%),10 patients were improved(27.8%)and 9 patients were dead(by cerebral hernia)(25.0%).Conclusion The examination of CSF is the most important method and can be regarded as one for judging therapeutic effect dynamicly with cryptococcal meningitis.
出处 《脑与神经疾病杂志》 2010年第3期187-189,共3页 Journal of Brain and Nervous Diseases
关键词 隐球菌性脑膜炎 脑脊液 治疗 Cryptococcal meningitis Cerebrospinal fluid Treatment
  • 相关文献

参考文献5

  • 1Dammert P,Bustamante B,Ticona E,et al.treatment of cryptococcal meningitis in peruv Treatment of cryptococcal meningitis in Peruvian AIDS Patients using amphotericin B and fluconazole.J Infection,2008,57:260-265.
  • 2Macsween KF,Bicanic T,Brouwer AE,et al.Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis:case report and review.J Infection,2005,51:221-224.
  • 3Larsen RA,Bauer M,Thomas AM,et al.Amphotericin B and fluconazole,a potent combination therapy for cryptococcal meningitis.Antimicrob Agents Chemother,2004,48:985-991.
  • 4Ray A,Anand S.Recent trends in antifungal therapy:focus on systemic mycoses.Indian J Chest Dis Allied Sci,2000,42:357-366.
  • 5Sasakawa A,Yamamoto Y,Yajima K,et al.Liposomal amphotericin B for a case of intractable cryptococcal meningoencephalitis and immune reconstitution syndrome.J Med Invest.2008,55:292-296.

同被引文献9

  • 1吕沛华,赵蓓蕾,施毅,文昱婷.1,3-β-D葡聚糖检测诊断侵袭性真菌感染的临床价值[J].中华结核和呼吸杂志,2007,30(1):31-34. 被引量:50
  • 2Mitchell TG,Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans[J].Clinical Microbiology Reviews,1995,(04):515-548.
  • 3Hachem RY,Kontoyiannis DP,Chemaly RF,Jiang Y Reitzel R Read I. Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan in diagnosis of invasive fungal infections:low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients[J].Journal of Clinical Microbiology,2009,(01):129-133.
  • 4Dalle F,Charles PE,Blanc K,Caillot D Chavanet P Dromer F. Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan[J].Journal of Clinical Microbiology,2005,(06):2929-2931.
  • 5Sivertsen EA,Torfoss D. Cryptococcal meningitis[J].Tidsskrift for den Norske laegeforening,2004,(01):28-30.
  • 6Perfect JR,Dismukes WE,Dromer F,Goldman DL Graybill JR Hamill R J. Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J].Clin Inefect Dis,2010,(03):291-322.doi:10.1086/649858.
  • 7van der Horst CM,Saag MS,Clood GA,Hamill RJ Graybill JR Sobel JD. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome[J].New England Journal of Medicine,1997,(01):15-21.
  • 8温海.隐球菌感染诊治专家共识[J].中国真菌学杂志,2010,5(2):65-68. 被引量:254
  • 9刘正印,王爱霞,李太生,秦树林,盛瑞媛.隐球菌性脑膜炎26例临床分析[J].中华内科杂志,2002,41(8):541-543. 被引量:41

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部